Ascentage Pharma Group International (AAPG) Non-Current Deffered Revenue (2023 - 2024)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Ascentage Pharma Group International (AAPG) has 2 years of Non-Current Deffered Revenue data on record, last reported at $3.8 million in Q4 2024.

• For Q4 2024, Non-Current Deffered Revenue fell 89.03% year-over-year to $3.8 million; the TTM value through Dec 2024 reached $3.8 million, down 89.03%, while the annual FY2024 figure was $3.8 million, 89.23% down from the prior year.
• Non-Current Deffered Revenue reached $3.8 million in Q4 2024 per AAPG's latest filing, down from $34.9 million in the prior quarter.
• Across five years, Non-Current Deffered Revenue topped out at $34.9 million in Q4 2023 and bottomed at $3.8 million in Q4 2024.

Peer Comparison